data_1oeh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oeh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.576 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 9.2 t-160 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.58 13.22 0.18 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-O 116.652 -2.193 . . . . 0.0 116.455 -159.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.68 -66.37 0.46 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 121.392 2.596 . . . . 0.0 110.371 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.19 18.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.507 0.563 . . . . 0.0 114.507 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.82 -129.89 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.125 0.962 . . . . 0.0 109.79 -159.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.05 -36.79 93.43 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.141 1.337 . . . . 0.0 112.96 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -48.88 -52.06 49.52 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 126.6 1.96 . . . . 0.0 114.055 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 122.712 2.275 . . . . 0.0 115.018 178.03 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.615 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 8.4 t-160 . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.615 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 147.08 9.79 0.21 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-O 116.494 -2.281 . . . . 0.0 116.207 -159.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.22 -69.09 0.4 Allowed Glycine 0 C--N 1.339 0.744 0 CA-C-N 121.519 2.66 . . . . 0.0 110.908 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.55 22.07 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.878 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.15 -135.2 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 0.0 109.806 -162.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.79 -35.67 87.28 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.381 0.991 . . . . 0.0 113.816 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.57 -61.51 3.75 Favored Pre-proline 0 N--CA 1.445 -0.692 0 C-N-CA 126.291 1.836 . . . . 0.0 111.729 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 C-N-CA 123.087 2.525 . . . . 0.0 114.279 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.572 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.572 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 148.17 5.37 0.29 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 116.494 -2.281 . . . . 0.0 115.915 -165.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.03 -63.61 0.45 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 121.623 2.711 . . . . 0.0 111.343 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.41 25.81 0.03 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 117.308 0.554 . . . . 0.0 113.891 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.86 -136.84 0.17 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.328 1.451 . . . . 0.0 109.249 -164.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.97 -18.83 74.85 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.954 1.252 . . . . 0.0 114.955 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -59.21 -60.22 11.26 Favored Pre-proline 0 N--CA 1.445 -0.725 0 C-N-CA 125.611 1.564 . . . . 0.0 111.474 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 C-N-CA 122.776 2.317 . . . . 0.0 110.024 173.075 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 124.064 1.887 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.62 35.07 0.13 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 127.498 2.475 . . . . 0.0 116.634 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.8 -24.45 5.76 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 120.198 1.999 . . . . 0.0 114.055 165.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.61 7.26 0.56 Allowed Glycine 0 N--CA 1.473 1.111 0 CA-C-N 118.968 1.384 . . . . 0.0 116.152 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -117.29 0.2 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.665 1.233 . . . . 0.0 110.758 -160.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.41 -12.2 76.76 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.103 0.865 . . . . 0.0 113.477 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.0 -50.25 0.99 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 O-C-N 121.07 -1.253 . . . . 0.0 110.017 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo . . . . . 0 CA--C 1.544 0.997 0 C-N-CA 122.73 2.287 . . . . 0.0 111.819 165.273 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 . . . . . 0 C--O 1.225 -0.198 0 CA-C-O 124.813 2.244 . . . . 0.0 114.916 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.63 37.63 0.87 Allowed Glycine 0 C--N 1.316 -0.58 0 CA-C-N 111.907 -2.406 . . . . 0.0 115.355 173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.28 8.44 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 120.004 1.902 . . . . 0.0 114.617 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.75 4.52 0.43 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 119.26 1.53 . . . . 0.0 116.429 165.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.38 -116.65 0.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.581 1.19 . . . . 0.0 110.562 -158.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.78 -29.11 74.39 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.084 -1.01 . . . . 0.0 112.616 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -72.75 -47.47 8.97 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.569 1.148 . . . . 0.0 112.448 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.348 0.547 0 CA-C-N 121.181 1.458 . . . . 0.0 111.808 168.208 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.657 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 12.9 t-80 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.657 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 147.28 13.53 0.16 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.346 -1.808 . . . . 0.0 115.453 -155.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.37 -77.23 0.33 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 120.805 2.302 . . . . 0.0 110.455 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.07 21.0 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.41 -0.661 . . . . 0.0 114.213 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.11 -136.5 0.24 Allowed 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 124.861 1.264 . . . . 0.0 108.693 -168.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.1 1.67 54.65 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.682 1.128 . . . . 0.0 115.054 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -81.67 -55.17 0.63 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 126.892 2.077 . . . . 0.0 109.885 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 121.515 1.477 . . . . 0.0 109.886 166.401 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.27 25.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.634 0 C-N-CA 127.501 2.477 . . . . 0.0 118.48 168.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.98 -77.29 0.38 Allowed Glycine 0 C--O 1.223 -0.567 0 CA-C-N 121.749 2.774 . . . . 0.0 111.028 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.61 19.65 0.03 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.438 -0.886 . . . . 0.0 114.768 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.25 -116.25 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -172.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.34 7.28 28.58 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.528 0.604 . . . . 0.0 113.846 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -72.11 -41.62 8.75 Favored Pre-proline 0 N--CA 1.445 -0.718 0 C-N-CA 123.952 0.901 . . . . 0.0 110.37 163.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.455 -0.791 0 N-CA-C 107.811 -1.649 . . . . 0.0 107.811 154.908 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 124.691 2.186 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.55 28.16 1.81 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 112.058 -2.337 . . . . 0.0 114.328 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.68 -14.54 9.19 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 119.952 1.876 . . . . 0.0 114.818 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.18 8.81 1.3 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 119.114 1.457 . . . . 0.0 115.945 161.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 -114.99 0.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.149 0.974 . . . . 0.0 109.879 -160.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.39 89.7 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.342 0.974 . . . . 0.0 114.47 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -84.31 -56.22 0.43 Allowed Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.576 1.15 . . . . 0.0 111.647 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.458 -0.563 0 CA-C-N 120.156 1.092 . . . . 0.0 109.415 170.226 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.73 21.5 9.03 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-O 117.105 -1.941 . . . . 0.0 113.548 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.46 -19.35 3.01 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 120.048 1.924 . . . . 0.0 113.759 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.8 13.13 2.29 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-N 118.603 1.202 . . . . 0.0 114.869 167.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 -104.49 0.39 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.16 0.98 . . . . 0.0 111.775 -159.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.55 27.9 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.504 1.047 . . . . 0.0 113.296 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 3.8 mp0 -65.68 -39.97 36.61 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.112 1.765 . . . . 0.0 114.874 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 18.5 Cg_endo . . . . . 0 CA--C 1.544 1.025 0 C-N-CA 124.824 3.683 . . . . 0.0 114.125 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.632 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 11.7 t-80 . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.632 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.1 10.94 0.23 Allowed Glycine 0 C--O 1.221 -0.691 0 CA-C-O 117.284 -1.842 . . . . 0.0 114.549 -158.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.02 -76.31 0.33 Allowed Glycine 0 C--O 1.225 -0.454 0 CA-C-N 120.841 2.32 . . . . 0.0 110.239 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.66 19.14 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.34 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.11 -138.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.971 1.308 . . . . 0.0 109.106 -164.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.33 34.37 0.95 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.109 1.338 . . . . 0.0 114.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -121.48 -56.83 0.03 OUTLIER Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 127.48 2.312 . . . . 0.0 110.417 177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 CA--C 1.546 1.086 0 C-N-CA 121.26 1.307 . . . . 0.0 110.483 159.142 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.639 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.639 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 142.04 17.08 0.33 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 117.565 -1.686 . . . . 0.0 115.497 -156.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.22 -73.89 0.41 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.838 2.319 . . . . 0.0 110.6 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.3 15.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.44 -0.645 . . . . 0.0 114.513 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -135.17 0.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.605 1.203 . . . . 0.0 110.113 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.36 -18.58 63.31 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.969 -1.082 . . . . 0.0 113.842 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -67.23 -58.6 8.69 Favored Pre-proline 0 N--CA 1.442 -0.858 0 C-N-CA 125.849 1.66 . . . . 0.0 109.946 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo . . . . . 0 N--CA 1.46 -0.445 0 C-N-CA 122.168 1.912 . . . . 0.0 113.943 171.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.64 3.99 0.39 Allowed Glycine 0 C--O 1.225 -0.458 0 CA-C-O 117.837 -1.535 . . . . 0.0 114.681 -165.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.11 -61.54 0.42 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.373 1.586 . . . . 0.0 110.45 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.49 30.74 0.12 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 124.425 0.72 . . . . 0.0 113.276 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.76 -115.71 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.277 1.431 . . . . 0.0 109.094 -168.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.16 -29.28 28.52 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.766 1.166 . . . . 0.0 113.95 -176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.76 -47.39 98.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.528 1.931 . . . . 0.0 114.298 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 N--CA 1.449 -1.119 0 C-N-CA 122.547 2.165 . . . . 0.0 111.384 -178.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.6 26.04 1.07 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.125 -1.93 . . . . 0.0 113.256 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.21 -73.64 0.39 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 120.269 2.035 . . . . 0.0 109.874 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.12 25.46 0.02 OUTLIER Glycine 0 CA--C 1.524 0.626 0 CA-C-N 117.488 0.644 . . . . 0.0 114.147 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.84 -143.75 0.28 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.473 1.109 . . . . 0.0 108.854 -167.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.35 11.04 4.28 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.094 0.861 . . . . 0.0 114.627 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 6.7 mm100 -83.45 -63.97 0.25 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 119.02 1.41 . . . . 0.0 107.899 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 55.7 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 122.75 2.3 . . . . 0.0 109.044 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.644 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 14.5 t-80 . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 121.602 0.715 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.644 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 155.3 9.74 0.07 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-O 116.838 -2.09 . . . . 0.0 115.522 -155.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.46 -69.36 0.41 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.899 2.35 . . . . 0.0 110.101 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 26.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.433 0.617 . . . . 0.0 114.485 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -117.65 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.334 1.054 . . . . 0.0 110.127 -164.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.38 -11.91 55.06 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.546 1.066 . . . . 0.0 113.722 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -63.99 -47.5 79.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.626 1.17 . . . . 0.0 111.502 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.454 -0.815 0 C-N-CA 121.63 1.554 . . . . 0.0 110.579 175.506 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.593 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 8.0 t-160 . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 120.337 0.113 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.593 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 141.7 12.17 0.5 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 116.827 -2.096 . . . . 0.0 115.505 -162.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.95 -68.17 0.47 Allowed Glycine 0 C--N 1.339 0.72 0 CA-C-N 121.348 2.574 . . . . 0.0 110.918 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.94 10.44 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.492 0.557 . . . . 0.0 114.492 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -139.44 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.259 1.029 . . . . 0.0 109.845 -158.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.46 11.7 1.1 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.41 1.481 . . . . 0.0 114.642 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -89.69 -71.53 0.07 OUTLIER Pre-proline 0 N--CA 1.432 -1.37 0 C-N-CA 126.037 1.735 . . . . 0.0 107.194 165.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.306 2.004 . . . . 0.0 115.033 -178.789 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.58 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 6.5 t-160 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.58 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 149.29 10.45 0.14 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.429 -1.762 . . . . 0.0 114.886 -164.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.65 -28.58 2.85 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.265 2.033 . . . . 0.0 113.17 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.75 12.87 1.68 Allowed Glycine 0 N--CA 1.471 0.971 0 CA-C-N 118.458 1.129 . . . . 0.0 114.59 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -105.24 0.32 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.266 1.033 . . . . 0.0 111.168 -158.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.26 -24.97 45.69 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.161 -0.962 . . . . 0.0 112.925 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -68.22 -50.21 30.56 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 118.542 1.171 . . . . 0.0 112.784 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 122.834 2.356 . . . . 0.0 112.58 -179.521 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . 0.252 2.7 t-160 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.39 37.86 0.04 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 128.474 2.94 . . . . 0.0 117.669 172.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.02 -91.14 0.26 Allowed Glycine 0 C--O 1.223 -0.578 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.7 20.78 0.07 OUTLIER Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.42 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.15 -129.41 0.18 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 118.358 1.079 . . . . 0.0 109.856 -161.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.01 19.4 3.47 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.849 -1.157 . . . . 0.0 115.236 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.515 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 13.1 mm100 -107.76 -47.16 0.11 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 110.491 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 27.7 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 C-N-CA 122.48 2.12 . . . . 0.0 109.27 152.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 C--O 1.227 -0.098 0 CA-C-O 124.598 2.142 . . . . 0.0 114.901 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.05 27.28 7.58 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 111.937 -2.392 . . . . 0.0 114.551 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.25 -28.3 3.87 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.543 2.172 . . . . 0.0 114.97 172.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.34 10.92 0.19 Allowed Glycine 0 N--CA 1.472 1.094 0 CA-C-N 119.252 1.526 . . . . 0.0 116.332 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -124.74 -113.11 0.3 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.451 1.125 . . . . 0.0 110.306 -161.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.58 -20.51 58.23 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.603 1.092 . . . . 0.0 113.738 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.39 -38.51 8.46 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.809 1.244 . . . . 0.0 112.117 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.544 0.977 0 C-N-CA 122.525 2.15 . . . . 0.0 111.138 166.533 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.671 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 9.2 t-80 . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.671 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 145.35 14.17 0.21 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-O 117.2 -1.889 . . . . 0.0 115.697 -155.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.68 -75.61 0.35 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 120.985 2.392 . . . . 0.0 110.482 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.56 18.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-N 117.265 0.532 . . . . 0.0 113.915 -174.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.59 -139.86 0.22 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.24 1.016 . . . . 0.0 108.784 -166.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.89 -9.5 53.18 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 121.287 -0.883 . . . . 0.0 114.828 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -71.25 -60.78 2.53 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 125.755 1.622 . . . . 0.0 109.867 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 CA-C-N 120.516 1.22 . . . . 0.0 110.488 169.322 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.71 42.08 0.09 OUTLIER Glycine 0 CA--C 1.521 0.424 0 C-N-CA 126.831 2.158 . . . . 0.0 117.471 171.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.37 -42.0 1.46 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 119.821 1.81 . . . . 0.0 112.693 166.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 6.96 0.09 OUTLIER Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -116.75 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.213 1.506 . . . . 0.0 111.129 -160.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.73 -3.43 54.91 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 114.139 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 mp0 -97.95 -46.63 0.23 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.737 1.615 . . . . 0.0 112.109 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.426 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 12.8 Cg_endo . . . . . 0 C--N 1.349 0.604 0 CA-C-N 120.602 1.251 . . . . 0.0 109.82 161.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.517 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 9.2 t-160 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.58 13.22 0.18 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-O 116.652 -2.193 . . . . 0.0 116.455 -159.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.68 -66.37 0.46 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 121.392 2.596 . . . . 0.0 110.371 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.19 18.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.507 0.563 . . . . 0.0 114.507 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.82 -129.89 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.125 0.962 . . . . 0.0 109.79 -159.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.05 -36.79 93.43 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.141 1.337 . . . . 0.0 112.96 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -48.88 -52.06 49.52 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 126.6 1.96 . . . . 0.0 114.055 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 122.712 2.275 . . . . 0.0 115.018 178.03 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.543 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 8.4 t-160 . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.543 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 147.08 9.79 0.21 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-O 116.494 -2.281 . . . . 0.0 116.207 -159.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.22 -69.09 0.4 Allowed Glycine 0 C--N 1.339 0.744 0 CA-C-N 121.519 2.66 . . . . 0.0 110.908 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.55 22.07 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.878 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.15 -135.2 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 0.0 109.806 -162.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.79 -35.67 87.28 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.381 0.991 . . . . 0.0 113.816 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.57 -61.51 3.75 Favored Pre-proline 0 N--CA 1.445 -0.692 0 C-N-CA 126.291 1.836 . . . . 0.0 111.729 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 C-N-CA 123.087 2.525 . . . . 0.0 114.279 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.523 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 148.17 5.37 0.29 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 116.494 -2.281 . . . . 0.0 115.915 -165.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.03 -63.61 0.45 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 121.623 2.711 . . . . 0.0 111.343 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.41 25.81 0.03 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 117.308 0.554 . . . . 0.0 113.891 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.86 -136.84 0.17 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.328 1.451 . . . . 0.0 109.249 -164.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.97 -18.83 74.85 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.954 1.252 . . . . 0.0 114.955 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -59.21 -60.22 11.26 Favored Pre-proline 0 N--CA 1.445 -0.725 0 C-N-CA 125.611 1.564 . . . . 0.0 111.474 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 C-N-CA 122.776 2.317 . . . . 0.0 110.024 173.075 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 124.064 1.887 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.62 35.07 0.13 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 127.498 2.475 . . . . 0.0 116.634 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.8 -24.45 5.76 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 120.198 1.999 . . . . 0.0 114.055 165.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.61 7.26 0.56 Allowed Glycine 0 N--CA 1.473 1.111 0 CA-C-N 118.968 1.384 . . . . 0.0 116.152 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -117.29 0.2 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.665 1.233 . . . . 0.0 110.758 -160.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.41 -12.2 76.76 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.103 0.865 . . . . 0.0 113.477 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.0 -50.25 0.99 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 O-C-N 121.07 -1.253 . . . . 0.0 110.017 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo . . . . . 0 CA--C 1.544 0.997 0 C-N-CA 122.73 2.287 . . . . 0.0 111.819 165.273 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 . . . . . 0 C--O 1.225 -0.198 0 CA-C-O 124.813 2.244 . . . . 0.0 114.916 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -73.63 37.63 0.87 Allowed Glycine 0 C--N 1.316 -0.58 0 CA-C-N 111.907 -2.406 . . . . 0.0 115.355 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.28 8.44 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 120.004 1.902 . . . . 0.0 114.617 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.75 4.52 0.43 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 119.26 1.53 . . . . 0.0 116.429 165.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.38 -116.65 0.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.581 1.19 . . . . 0.0 110.562 -158.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.78 -29.11 74.39 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.084 -1.01 . . . . 0.0 112.616 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB3' ' H ' ' A' ' 62' ' ' GLY . 3.3 mp0 -72.75 -47.47 8.97 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.569 1.148 . . . . 0.0 112.448 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.348 0.547 0 CA-C-N 121.181 1.458 . . . . 0.0 111.808 168.208 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.588 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 12.9 t-80 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.588 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 147.28 13.53 0.16 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.346 -1.808 . . . . 0.0 115.453 -155.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.37 -77.23 0.33 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 120.805 2.302 . . . . 0.0 110.455 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.07 21.0 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.41 -0.661 . . . . 0.0 114.213 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.11 -136.5 0.24 Allowed 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 124.861 1.264 . . . . 0.0 108.693 -168.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.1 1.67 54.65 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.682 1.128 . . . . 0.0 115.054 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -81.67 -55.17 0.63 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 126.892 2.077 . . . . 0.0 109.885 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 121.515 1.477 . . . . 0.0 109.886 166.401 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -57.27 25.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.634 0 C-N-CA 127.501 2.477 . . . . 0.0 118.48 168.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.98 -77.29 0.38 Allowed Glycine 0 C--O 1.223 -0.567 0 CA-C-N 121.749 2.774 . . . . 0.0 111.028 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.61 19.65 0.03 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.438 -0.886 . . . . 0.0 114.768 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.25 -116.25 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -172.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.34 7.28 28.58 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.528 0.604 . . . . 0.0 113.846 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.475 ' HB3' ' H ' ' A' ' 62' ' ' GLY . 2.6 mp0 -72.11 -41.62 8.75 Favored Pre-proline 0 N--CA 1.445 -0.718 0 C-N-CA 123.952 0.901 . . . . 0.0 110.37 163.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.455 -0.791 0 N-CA-C 107.811 -1.649 . . . . 0.0 107.811 154.908 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 124.691 2.186 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.55 28.16 1.81 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 112.058 -2.337 . . . . 0.0 114.328 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.68 -14.54 9.19 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 119.952 1.876 . . . . 0.0 114.818 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.18 8.81 1.3 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 119.114 1.457 . . . . 0.0 115.945 161.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 -114.99 0.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.149 0.974 . . . . 0.0 109.879 -160.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.39 89.7 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.342 0.974 . . . . 0.0 114.47 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -84.31 -56.22 0.43 Allowed Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.576 1.15 . . . . 0.0 111.647 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.458 -0.563 0 CA-C-N 120.156 1.092 . . . . 0.0 109.415 170.226 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.73 21.5 9.03 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-O 117.105 -1.941 . . . . 0.0 113.548 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.46 -19.35 3.01 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 120.048 1.924 . . . . 0.0 113.759 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.8 13.13 2.29 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-N 118.603 1.202 . . . . 0.0 114.869 167.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 -104.49 0.39 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.16 0.98 . . . . 0.0 111.775 -159.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.55 27.9 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.504 1.047 . . . . 0.0 113.296 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 3.8 mp0 -65.68 -39.97 36.61 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.112 1.765 . . . . 0.0 114.874 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 18.5 Cg_endo . . . . . 0 CA--C 1.544 1.025 0 C-N-CA 124.824 3.683 . . . . 0.0 114.125 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 11.7 t-80 . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.581 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.1 10.94 0.23 Allowed Glycine 0 C--O 1.221 -0.691 0 CA-C-O 117.284 -1.842 . . . . 0.0 114.549 -158.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.02 -76.31 0.33 Allowed Glycine 0 C--O 1.225 -0.454 0 CA-C-N 120.841 2.32 . . . . 0.0 110.239 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.66 19.14 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.34 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.11 -138.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.971 1.308 . . . . 0.0 109.106 -164.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.33 34.37 0.95 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.109 1.338 . . . . 0.0 114.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 13.7 mm100 -121.48 -56.83 0.03 OUTLIER Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 127.48 2.312 . . . . 0.0 110.417 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 58.8 Cg_endo . . . . . 0 CA--C 1.546 1.086 0 C-N-CA 121.26 1.307 . . . . 0.0 110.483 159.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.576 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 142.04 17.08 0.33 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 117.565 -1.686 . . . . 0.0 115.497 -156.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.22 -73.89 0.41 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.838 2.319 . . . . 0.0 110.6 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.3 15.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.44 -0.645 . . . . 0.0 114.513 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -135.17 0.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.605 1.203 . . . . 0.0 110.113 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.36 -18.58 63.31 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.969 -1.082 . . . . 0.0 113.842 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -67.23 -58.6 8.69 Favored Pre-proline 0 N--CA 1.442 -0.858 0 C-N-CA 125.849 1.66 . . . . 0.0 109.946 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo . . . . . 0 N--CA 1.46 -0.445 0 C-N-CA 122.168 1.912 . . . . 0.0 113.943 171.97 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.64 3.99 0.39 Allowed Glycine 0 C--O 1.225 -0.458 0 CA-C-O 117.837 -1.535 . . . . 0.0 114.681 -165.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.11 -61.54 0.42 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.373 1.586 . . . . 0.0 110.45 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.49 30.74 0.12 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 124.425 0.72 . . . . 0.0 113.276 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.76 -115.71 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.277 1.431 . . . . 0.0 109.094 -168.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.16 -29.28 28.52 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.766 1.166 . . . . 0.0 113.95 -176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -55.76 -47.39 98.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.528 1.931 . . . . 0.0 114.298 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 N--CA 1.449 -1.119 0 C-N-CA 122.547 2.165 . . . . 0.0 111.384 -178.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 21.9 t-80 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.6 26.04 1.07 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.125 -1.93 . . . . 0.0 113.256 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.21 -73.64 0.39 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 120.269 2.035 . . . . 0.0 109.874 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.12 25.46 0.02 OUTLIER Glycine 0 CA--C 1.524 0.626 0 CA-C-N 117.488 0.644 . . . . 0.0 114.147 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.84 -143.75 0.28 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.473 1.109 . . . . 0.0 108.854 -167.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.35 11.04 4.28 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.094 0.861 . . . . 0.0 114.627 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.435 ' CB ' ' CD ' ' A' ' 68' ' ' PRO . 6.7 mm100 -83.45 -63.97 0.25 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 119.02 1.41 . . . . 0.0 107.899 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 67' ' ' GLN . 55.7 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 122.75 2.3 . . . . 0.0 109.044 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.563 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 14.5 t-80 . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 121.602 0.715 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 155.3 9.74 0.07 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-O 116.838 -2.09 . . . . 0.0 115.522 -155.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.46 -69.36 0.41 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.899 2.35 . . . . 0.0 110.101 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 26.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.433 0.617 . . . . 0.0 114.485 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -117.65 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.334 1.054 . . . . 0.0 110.127 -164.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.38 -11.91 55.06 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.546 1.066 . . . . 0.0 113.722 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -63.99 -47.5 79.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.626 1.17 . . . . 0.0 111.502 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.454 -0.815 0 C-N-CA 121.63 1.554 . . . . 0.0 110.579 175.506 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.539 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 8.0 t-160 . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 120.337 0.113 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.539 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 141.7 12.17 0.5 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 116.827 -2.096 . . . . 0.0 115.505 -162.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.95 -68.17 0.47 Allowed Glycine 0 C--N 1.339 0.72 0 CA-C-N 121.348 2.574 . . . . 0.0 110.918 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.94 10.44 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.492 0.557 . . . . 0.0 114.492 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -139.44 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.259 1.029 . . . . 0.0 109.845 -158.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.46 11.7 1.1 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.41 1.481 . . . . 0.0 114.642 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -89.69 -71.53 0.07 OUTLIER Pre-proline 0 N--CA 1.432 -1.37 0 C-N-CA 126.037 1.735 . . . . 0.0 107.194 165.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.306 2.004 . . . . 0.0 115.033 -178.789 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.53 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 6.5 t-160 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.53 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 149.29 10.45 0.14 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.429 -1.762 . . . . 0.0 114.886 -164.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.65 -28.58 2.85 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.265 2.033 . . . . 0.0 113.17 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.75 12.87 1.68 Allowed Glycine 0 N--CA 1.471 0.971 0 CA-C-N 118.458 1.129 . . . . 0.0 114.59 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -105.24 0.32 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.266 1.033 . . . . 0.0 111.168 -158.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.26 -24.97 45.69 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.161 -0.962 . . . . 0.0 112.925 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -68.22 -50.21 30.56 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 118.542 1.171 . . . . 0.0 112.784 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 122.834 2.356 . . . . 0.0 112.58 -179.521 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . 0.252 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -60.39 37.86 0.04 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 128.474 2.94 . . . . 0.0 117.669 172.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.02 -91.14 0.26 Allowed Glycine 0 C--O 1.223 -0.578 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.7 20.78 0.07 OUTLIER Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.42 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.15 -129.41 0.18 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 118.358 1.079 . . . . 0.0 109.856 -161.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.01 19.4 3.47 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.849 -1.157 . . . . 0.0 115.236 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.605 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 13.1 mm100 -107.76 -47.16 0.11 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 110.491 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 27.7 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 C-N-CA 122.48 2.12 . . . . 0.0 109.27 152.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 C--O 1.227 -0.098 0 CA-C-O 124.598 2.142 . . . . 0.0 114.901 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.05 27.28 7.58 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 111.937 -2.392 . . . . 0.0 114.551 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.25 -28.3 3.87 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.543 2.172 . . . . 0.0 114.97 172.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.34 10.92 0.19 Allowed Glycine 0 N--CA 1.472 1.094 0 CA-C-N 119.252 1.526 . . . . 0.0 116.332 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -124.74 -113.11 0.3 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.451 1.125 . . . . 0.0 110.306 -161.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.58 -20.51 58.23 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.603 1.092 . . . . 0.0 113.738 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.39 -38.51 8.46 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.809 1.244 . . . . 0.0 112.117 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.544 0.977 0 C-N-CA 122.525 2.15 . . . . 0.0 111.138 166.533 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.613 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 9.2 t-80 . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.613 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 145.35 14.17 0.21 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-O 117.2 -1.889 . . . . 0.0 115.697 -155.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.68 -75.61 0.35 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 120.985 2.392 . . . . 0.0 110.482 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.56 18.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-N 117.265 0.532 . . . . 0.0 113.915 -174.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.59 -139.86 0.22 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.24 1.016 . . . . 0.0 108.784 -166.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.89 -9.5 53.18 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 121.287 -0.883 . . . . 0.0 114.828 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -71.25 -60.78 2.53 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 125.755 1.622 . . . . 0.0 109.867 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 CA-C-N 120.516 1.22 . . . . 0.0 110.488 169.322 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.71 42.08 0.09 OUTLIER Glycine 0 CA--C 1.521 0.424 0 C-N-CA 126.831 2.158 . . . . 0.0 117.471 171.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.37 -42.0 1.46 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 119.821 1.81 . . . . 0.0 112.693 166.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 6.96 0.09 OUTLIER Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -116.75 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.213 1.506 . . . . 0.0 111.129 -160.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.73 -3.43 54.91 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 114.139 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.503 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 mp0 -97.95 -46.63 0.23 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.737 1.615 . . . . 0.0 112.109 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 12.8 Cg_endo . . . . . 0 C--N 1.349 0.604 0 CA-C-N 120.602 1.251 . . . . 0.0 109.82 161.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.517 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 9.2 t-160 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.517 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.58 13.22 0.18 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-O 116.652 -2.193 . . . . 0.0 116.455 -159.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.68 -66.37 0.46 Allowed Glycine 0 C--N 1.338 0.64 0 CA-C-N 121.392 2.596 . . . . 0.0 110.371 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 165.19 18.75 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.507 0.563 . . . . 0.0 114.507 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.82 -129.89 0.2 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.125 0.962 . . . . 0.0 109.79 -159.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.05 -36.79 93.43 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.141 1.337 . . . . 0.0 112.96 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -48.88 -52.06 49.52 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 126.6 1.96 . . . . 0.0 114.055 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 CA--C 1.538 0.723 0 C-N-CA 122.712 2.275 . . . . 0.0 115.018 178.03 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.543 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 8.4 t-160 . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.543 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 147.08 9.79 0.21 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-O 116.494 -2.281 . . . . 0.0 116.207 -159.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.22 -69.09 0.4 Allowed Glycine 0 C--N 1.339 0.744 0 CA-C-N 121.519 2.66 . . . . 0.0 110.908 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 164.55 22.07 0.02 OUTLIER Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.75 -0.472 . . . . 0.0 113.878 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.15 -135.2 0.2 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 0.0 109.806 -162.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -59.79 -35.67 87.28 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.381 0.991 . . . . 0.0 113.816 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.57 -61.51 3.75 Favored Pre-proline 0 N--CA 1.445 -0.692 0 C-N-CA 126.291 1.836 . . . . 0.0 111.729 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.542 0.9 0 C-N-CA 123.087 2.525 . . . . 0.0 114.279 176.48 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.523 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 148.17 5.37 0.29 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-O 116.494 -2.281 . . . . 0.0 115.915 -165.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.03 -63.61 0.45 Allowed Glycine 0 C--N 1.34 0.775 0 CA-C-N 121.623 2.711 . . . . 0.0 111.343 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.41 25.81 0.03 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-N 117.308 0.554 . . . . 0.0 113.891 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.86 -136.84 0.17 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 125.328 1.451 . . . . 0.0 109.249 -164.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.97 -18.83 74.85 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.954 1.252 . . . . 0.0 114.955 -173.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -59.21 -60.22 11.26 Favored Pre-proline 0 N--CA 1.445 -0.725 0 C-N-CA 125.611 1.564 . . . . 0.0 111.474 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 C-N-CA 122.776 2.317 . . . . 0.0 110.024 173.075 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 124.064 1.887 . . . . 0.0 114.236 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.62 35.07 0.13 Allowed Glycine 0 CA--C 1.522 0.479 0 C-N-CA 127.498 2.475 . . . . 0.0 116.634 172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.8 -24.45 5.76 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 120.198 1.999 . . . . 0.0 114.055 165.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 143.61 7.26 0.56 Allowed Glycine 0 N--CA 1.473 1.111 0 CA-C-N 118.968 1.384 . . . . 0.0 116.152 168.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -117.29 0.2 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.665 1.233 . . . . 0.0 110.758 -160.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.41 -12.2 76.76 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.103 0.865 . . . . 0.0 113.477 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.0 -50.25 0.99 Allowed Pre-proline 0 N--CA 1.448 -0.565 0 O-C-N 121.07 -1.253 . . . . 0.0 110.017 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo . . . . . 0 CA--C 1.544 0.997 0 C-N-CA 122.73 2.287 . . . . 0.0 111.819 165.273 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 . . . . . 0 C--O 1.225 -0.198 0 CA-C-O 124.813 2.244 . . . . 0.0 114.916 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -73.63 37.63 0.87 Allowed Glycine 0 C--N 1.316 -0.58 0 CA-C-N 111.907 -2.406 . . . . 0.0 115.355 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.32 -20.28 8.44 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 120.004 1.902 . . . . 0.0 114.617 165.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.75 4.52 0.43 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 119.26 1.53 . . . . 0.0 116.429 165.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.38 -116.65 0.19 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.581 1.19 . . . . 0.0 110.562 -158.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.78 -29.11 74.39 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.084 -1.01 . . . . 0.0 112.616 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.462 ' HB3' ' H ' ' A' ' 62' ' ' GLY . 3.3 mp0 -72.75 -47.47 8.97 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.569 1.148 . . . . 0.0 112.448 -174.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 C--N 1.348 0.547 0 CA-C-N 121.181 1.458 . . . . 0.0 111.808 168.208 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.588 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 12.9 t-80 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.588 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 147.28 13.53 0.16 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-O 117.346 -1.808 . . . . 0.0 115.453 -155.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.37 -77.23 0.33 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 120.805 2.302 . . . . 0.0 110.455 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 171.07 21.0 0.02 OUTLIER Glycine 0 CA--C 1.527 0.784 0 CA-C-O 119.41 -0.661 . . . . 0.0 114.213 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.11 -136.5 0.24 Allowed 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 124.861 1.264 . . . . 0.0 108.693 -168.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.1 1.67 54.65 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 119.682 1.128 . . . . 0.0 115.054 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -81.67 -55.17 0.63 Allowed Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 126.892 2.077 . . . . 0.0 109.885 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.457 -0.628 0 C-N-CA 121.515 1.477 . . . . 0.0 109.886 166.401 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -57.27 25.63 0.01 OUTLIER Glycine 0 CA--C 1.524 0.634 0 C-N-CA 127.501 2.477 . . . . 0.0 118.48 168.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.98 -77.29 0.38 Allowed Glycine 0 C--O 1.223 -0.567 0 CA-C-N 121.749 2.774 . . . . 0.0 111.028 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.61 19.65 0.03 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.438 -0.886 . . . . 0.0 114.768 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.25 -116.25 0.32 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -172.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.34 7.28 28.58 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 118.528 0.604 . . . . 0.0 113.846 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.475 ' HB3' ' H ' ' A' ' 62' ' ' GLY . 2.6 mp0 -72.11 -41.62 8.75 Favored Pre-proline 0 N--CA 1.445 -0.718 0 C-N-CA 123.952 0.901 . . . . 0.0 110.37 163.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo . . . . . 0 N--CA 1.455 -0.791 0 N-CA-C 107.811 -1.649 . . . . 0.0 107.811 154.908 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 . . . . . 0 C--O 1.227 -0.085 0 CA-C-O 124.691 2.186 . . . . 0.0 113.727 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.55 28.16 1.81 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 112.058 -2.337 . . . . 0.0 114.328 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.68 -14.54 9.19 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 119.952 1.876 . . . . 0.0 114.818 169.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.18 8.81 1.3 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 119.114 1.457 . . . . 0.0 115.945 161.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.79 -114.99 0.24 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.149 0.974 . . . . 0.0 109.879 -160.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.2 -5.39 89.7 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.342 0.974 . . . . 0.0 114.47 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -84.31 -56.22 0.43 Allowed Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 124.576 1.15 . . . . 0.0 111.647 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.458 -0.563 0 CA-C-N 120.156 1.092 . . . . 0.0 109.415 170.226 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -119.73 21.5 9.03 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-O 117.105 -1.941 . . . . 0.0 113.548 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.46 -19.35 3.01 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 120.048 1.924 . . . . 0.0 113.759 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 129.8 13.13 2.29 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-N 118.603 1.202 . . . . 0.0 114.869 167.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 -104.49 0.39 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.16 0.98 . . . . 0.0 111.775 -159.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.12 -28.55 27.9 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 119.504 1.047 . . . . 0.0 113.296 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.437 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 3.8 mp0 -65.68 -39.97 36.61 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 126.112 1.765 . . . . 0.0 114.874 -178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 18.5 Cg_endo . . . . . 0 CA--C 1.544 1.025 0 C-N-CA 124.824 3.683 . . . . 0.0 114.125 -174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.581 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 11.7 t-80 . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.581 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.1 10.94 0.23 Allowed Glycine 0 C--O 1.221 -0.691 0 CA-C-O 117.284 -1.842 . . . . 0.0 114.549 -158.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.02 -76.31 0.33 Allowed Glycine 0 C--O 1.225 -0.454 0 CA-C-N 120.841 2.32 . . . . 0.0 110.239 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.66 19.14 0.02 OUTLIER Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.839 -0.696 . . . . 0.0 114.34 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.11 -138.39 0.18 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.971 1.308 . . . . 0.0 109.106 -164.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.33 34.37 0.95 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.109 1.338 . . . . 0.0 114.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 13.7 mm100 -121.48 -56.83 0.03 OUTLIER Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 127.48 2.312 . . . . 0.0 110.417 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 58.8 Cg_endo . . . . . 0 CA--C 1.546 1.086 0 C-N-CA 121.26 1.307 . . . . 0.0 110.483 159.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.576 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.576 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 142.04 17.08 0.33 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 117.565 -1.686 . . . . 0.0 115.497 -156.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.22 -73.89 0.41 Allowed Glycine 0 C--N 1.338 0.669 0 CA-C-N 120.838 2.319 . . . . 0.0 110.6 174.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.3 15.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.44 -0.645 . . . . 0.0 114.513 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -135.17 0.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.605 1.203 . . . . 0.0 110.113 -162.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.36 -18.58 63.31 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 120.969 -1.082 . . . . 0.0 113.842 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -67.23 -58.6 8.69 Favored Pre-proline 0 N--CA 1.442 -0.858 0 C-N-CA 125.849 1.66 . . . . 0.0 109.946 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo . . . . . 0 N--CA 1.46 -0.445 0 C-N-CA 122.168 1.912 . . . . 0.0 113.943 171.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.64 3.99 0.39 Allowed Glycine 0 C--O 1.225 -0.458 0 CA-C-O 117.837 -1.535 . . . . 0.0 114.681 -165.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.11 -61.54 0.42 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.373 1.586 . . . . 0.0 110.45 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.49 30.74 0.12 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 124.425 0.72 . . . . 0.0 113.276 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.76 -115.71 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 125.277 1.431 . . . . 0.0 109.094 -168.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.16 -29.28 28.52 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 119.766 1.166 . . . . 0.0 113.95 -176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -55.76 -47.39 98.83 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.528 1.931 . . . . 0.0 114.298 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 N--CA 1.449 -1.119 0 C-N-CA 122.547 2.165 . . . . 0.0 111.384 -178.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 21.9 t-80 . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.6 26.04 1.07 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-O 117.125 -1.93 . . . . 0.0 113.256 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.21 -73.64 0.39 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-N 120.269 2.035 . . . . 0.0 109.874 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 169.12 25.46 0.02 OUTLIER Glycine 0 CA--C 1.524 0.626 0 CA-C-N 117.488 0.644 . . . . 0.0 114.147 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.84 -143.75 0.28 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 124.473 1.109 . . . . 0.0 108.854 -167.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.35 11.04 4.28 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.094 0.861 . . . . 0.0 114.627 -176.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.435 ' CB ' ' CD ' ' A' ' 68' ' ' PRO . 6.7 mm100 -83.45 -63.97 0.25 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 119.02 1.41 . . . . 0.0 107.899 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 67' ' ' GLN . 55.7 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 122.75 2.3 . . . . 0.0 109.044 172.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.563 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 14.5 t-80 . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 121.602 0.715 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.563 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 155.3 9.74 0.07 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-O 116.838 -2.09 . . . . 0.0 115.522 -155.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.46 -69.36 0.41 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 120.899 2.35 . . . . 0.0 110.101 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 161.88 26.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.805 0 CA-C-N 117.433 0.617 . . . . 0.0 114.485 -178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.1 -117.65 0.27 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.334 1.054 . . . . 0.0 110.127 -164.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.38 -11.91 55.06 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.546 1.066 . . . . 0.0 113.722 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -63.99 -47.5 79.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.626 1.17 . . . . 0.0 111.502 173.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.454 -0.815 0 C-N-CA 121.63 1.554 . . . . 0.0 110.579 175.506 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.539 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 8.0 t-160 . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 120.337 0.113 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.539 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 141.7 12.17 0.5 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 116.827 -2.096 . . . . 0.0 115.505 -162.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.95 -68.17 0.47 Allowed Glycine 0 C--N 1.339 0.72 0 CA-C-N 121.348 2.574 . . . . 0.0 110.918 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.94 10.44 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 114.492 0.557 . . . . 0.0 114.492 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -139.44 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.259 1.029 . . . . 0.0 109.845 -158.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.46 11.7 1.1 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.41 1.481 . . . . 0.0 114.642 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -89.69 -71.53 0.07 OUTLIER Pre-proline 0 N--CA 1.432 -1.37 0 C-N-CA 126.037 1.735 . . . . 0.0 107.194 165.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 C--N 1.35 0.609 0 C-N-CA 122.306 2.004 . . . . 0.0 115.033 -178.789 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.53 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 6.5 t-160 . . . . . 0 CA--C 1.539 0.545 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.53 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 149.29 10.45 0.14 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.429 -1.762 . . . . 0.0 114.886 -164.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 136.65 -28.58 2.85 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 120.265 2.033 . . . . 0.0 113.17 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.75 12.87 1.68 Allowed Glycine 0 N--CA 1.471 0.971 0 CA-C-N 118.458 1.129 . . . . 0.0 114.59 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -105.24 0.32 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.266 1.033 . . . . 0.0 111.168 -158.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.26 -24.97 45.69 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 121.161 -0.962 . . . . 0.0 112.925 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -68.22 -50.21 30.56 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 118.542 1.171 . . . . 0.0 112.784 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 C-N-CA 122.834 2.356 . . . . 0.0 112.58 -179.521 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . 0.252 2.7 t-160 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -60.39 37.86 0.04 OUTLIER Glycine 0 CA--C 1.522 0.49 0 C-N-CA 128.474 2.94 . . . . 0.0 117.669 172.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 133.02 -91.14 0.26 Allowed Glycine 0 C--O 1.223 -0.578 0 N-CA-C 107.185 -2.366 . . . . 0.0 107.185 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.7 20.78 0.07 OUTLIER Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.42 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.15 -129.41 0.18 Allowed 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 118.358 1.079 . . . . 0.0 109.856 -161.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.01 19.4 3.47 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 120.849 -1.157 . . . . 0.0 115.236 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.605 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 13.1 mm100 -107.76 -47.16 0.11 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 C-N-CA 126.429 1.891 . . . . 0.0 110.491 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.605 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 27.7 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 C-N-CA 122.48 2.12 . . . . 0.0 109.27 152.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 C--O 1.227 -0.098 0 CA-C-O 124.598 2.142 . . . . 0.0 114.901 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.05 27.28 7.58 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 111.937 -2.392 . . . . 0.0 114.551 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.25 -28.3 3.87 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.543 2.172 . . . . 0.0 114.97 172.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.34 10.92 0.19 Allowed Glycine 0 N--CA 1.472 1.094 0 CA-C-N 119.252 1.526 . . . . 0.0 116.332 168.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 65' ' ' TRP . 0.0 OUTLIER -124.74 -113.11 0.3 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.451 1.125 . . . . 0.0 110.306 -161.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -84.58 -20.51 58.23 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.603 1.092 . . . . 0.0 113.738 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.39 -38.51 8.46 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.809 1.244 . . . . 0.0 112.117 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.544 0.977 0 C-N-CA 122.525 2.15 . . . . 0.0 111.138 166.533 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.613 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 9.2 t-80 . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.613 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 145.35 14.17 0.21 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-O 117.2 -1.889 . . . . 0.0 115.697 -155.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.68 -75.61 0.35 Allowed Glycine 0 C--N 1.337 0.608 0 CA-C-N 120.985 2.392 . . . . 0.0 110.482 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 172.56 18.04 0.02 OUTLIER Glycine 0 CA--C 1.528 0.882 0 CA-C-N 117.265 0.532 . . . . 0.0 113.915 -174.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.59 -139.86 0.22 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.24 1.016 . . . . 0.0 108.784 -166.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.89 -9.5 53.18 Favored Glycine 0 CA--C 1.532 1.105 0 O-C-N 121.287 -0.883 . . . . 0.0 114.828 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -71.25 -60.78 2.53 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 125.755 1.622 . . . . 0.0 109.867 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.456 -0.719 0 CA-C-N 120.516 1.22 . . . . 0.0 110.488 169.322 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.71 42.08 0.09 OUTLIER Glycine 0 CA--C 1.521 0.424 0 C-N-CA 126.831 2.158 . . . . 0.0 117.471 171.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.37 -42.0 1.46 Allowed Glycine 0 CA--C 1.523 0.565 0 CA-C-N 119.821 1.81 . . . . 0.0 112.693 166.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.96 6.96 0.09 OUTLIER Glycine 0 CA--C 1.529 0.968 0 N-CA-C 115.805 1.082 . . . . 0.0 115.805 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.33 -116.75 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.213 1.506 . . . . 0.0 111.129 -160.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.73 -3.43 54.91 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 121.022 -1.049 . . . . 0.0 114.139 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.503 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 3.3 mp0 -97.95 -46.63 0.23 Allowed Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.737 1.615 . . . . 0.0 112.109 -177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 12.8 Cg_endo . . . . . 0 C--N 1.349 0.604 0 CA-C-N 120.602 1.251 . . . . 0.0 109.82 161.406 . . . . . . . . 1 1 . 1 stop_ save_